Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
US7884117B2 · kind B2 · utility
39Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2006 |
| Grant date | Feb 8, 2011 |
| Priority date | — |
| Expiry date | Jun 20, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Carbonylamino Pyrrolopyrazole compounds of formula I, compositions including these compounds and methods of their use are provided. Preferred compounds of formula I have activity as protein kinase inhibitors, including as inhibitors of PAK4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.